Canlyniadau Chwilio - Dennis Dong Hwan Kim

Mireinio'r Canlyniadau
  1. 1
    Musculoskeletal Complications of Diabetes Mellitus

    Musculoskeletal Complications of Diabetes Mellitus gan Rachel Peterson Kim, Steven V. Edelman, Dennis Dong Hwan Kim

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes gan John B. Buse, Robert R. Henry, Jenny Han, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea gan David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

    Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus gan Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen, James A. Ruggles, Loretta L. Nielsen, Mark Fineman, Alain Baron

    Cyhoeddwyd 2005
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes

    Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes gan Frauke Fehse, Michael Trautmann, Jens J. Holst, Amy E. Halseth, Nuwan D. Nanayakkara, Loretta L. Nielsen, Mark Fineman, Dennis Dong Hwan Kim, Michael A. Nauck

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes

    Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes gan Christian Weyer, Alan Gottlieb, Dennis Dong Hwan Kim, Karen Lutz, Sherwyn Schwartz, María Eugenia Hernández Gutiérrez, Yan Wang, James A. Ruggles, Orville Kolterman, David Maggs

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploi... gan Arjun Law, María Queralt Salas, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Rajat Kumar, Hans A. Messner, Auro Viswabandya

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease

    Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease gan Alistair Murray, Swe Mar Linn, Benoit Yu, Igor Novitzky‐Basso, Jonas Mattsson, Michael Kennah, Mohamed Elemary, Jennifer White, Christopher Lemieux, Kareem Jamani, Dennis Dong Hwan Kim

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects

    Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects gan Theodore P. Ciaraldi, Alice P.S. Kong, Neelima V. Chu, Dennis Dong Hwan Kim, Sunita Baxi, Mattias Loviscach, Ray Plodkowski, Richard E. Reitz, Michael P. Caulfield, Sunder Mudaliar, Robert R. Henry

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

    Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes gan Neelima V. Chu, Alice P.S. Kong, Dennis Dong Hwan Kim, Debra Armstrong, Sunita Baxi, Reena Deutsch, Michael P. Caulfield, Sunder Mudaliar, Richard E. Reitz, Robert R. Henry, Peter D. Reaven

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

    Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy gan Tae‐Hyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, Jae-Sook Ahn, Seung Hyun Choi, Hee Jeong Park, Yeo‐Kyeoung Kim, Soo Young Kim, Jeffrey H. Lipton, Zhaolei Zhang, Dennis Dong Hwan Kim

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

    European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia gan Nicholas C.P. Cross, Thomas Ernst, Susan Branford, Jean‐Michel Cayuela, Michael W. Deininger, Alice Fabarius, Dennis Dong Hwan Kim, Kateřina Machová Poláková, Jerald P. Radich, Rüdiger Hehlmann, Andreas Hochhaus, Jane F. Apperley, Simona Soverini

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia

    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia gan Richard T. Maziarz, Mark J. Levis, Mrinal M. Patnaik, Bart L. Scott, Sanjay Mohan, Abhinav Deol, Scott D. Rowley, Dennis Dong Hwan Kim, Daniela Hernandez, Trivikram Rajkhowa, Kelly Haines, Gaetano Bonifacio, Patrice Rine, Das Purkayastha, Hugo F. Fernández

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

    Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial gan Thomas A. Wadden, John P. Foreyt, Gary D. Foster, James O. Hill, Samuel Klein, Patrick M. O’Neil, Michael G. Perri, F. Xavier Pi‐Sunyer, Cheryl L. Rock, J. Erickson, Holly Maier, Dennis Dong Hwan Kim, Eduardo Dunayevich

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

    Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia gan Susan Branford, Dennis Dong Hwan Kim, Jane F. Apperley, Christopher A. Eide, Satu Mustjoki, S. Tiong Ong, Georgios Nteliopoulos, Thomas Ernst, Charles Chuah, Carlo Gambacorti‐Passerini, Michael J. Mauro, Brian J. Druker, Dong‐Wook Kim, François‐Xavier Mahon, Jorge E. Cortés, Jerry Radich, Andreas Hochhaus, Timothy P. Hughes

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations

    Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations gan Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Courtney E. Hershberger, Ying Ni, Jaymeson Gordon, Hetty E. Carraway, Richard A. Padgett, Diego F. Coutinho, Ilana Zalcberg, Jae‐Sook Ahn, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim, Mark D. Minden, Joop H. Jansen, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

    DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Tr... gan Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Seun-Shin Lee, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Nan Young Kim, Seung Hyun Choi, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon, Sang Kyun Sohn, Jong-Ho Won, Sung‐Hyun Kim, Dennis Dong Hwan Kim

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    <i>TET2</i> mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes

    <i>TET2</i> mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes gan Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Vera Ademà, Courtney E. Hershberger, Ying Ni, Hassan Awada, Sunisa Kongkiatkamon, Misam Zawit, Diego F. Coutinho, Ilana Zalcberg, Jae-Sook Ahn, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim, Mark D. Minden, Joop H. Jansen, Manja Meggendorfer, Claudia Haferlach, Babal K. Jha, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

    Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse gan Tae‐Hyung Kim, Joon Ho Moon, Jae-Sook Ahn, Yeo‐Kyeoung Kim, Seung-Shin Lee, Seo-Yeon Ahn, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Seung Hyun Choi, Ja-Yeon Lee, Marc S. Tyndel, Myung‐Geun Shin, Yoo Jin Lee, Sang Kyun Sohn, Seong-Kyu Park, Zhaolei Zhang, Hyeoung‐Joon Kim, Dennis Dong Hwan Kim

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population

    Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic M... gan Michael J. Mauro, Yosuke Minami, Andreas Hochhaus, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong‐Wook Kim, Jane F. Apperley, Jorge E. Cortés, André Abdo, Laura Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saußele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Lynette Chee, Valentín García‐Gutiérrez, Koji Sasaki, C. FREITAS, S. S. Kapoor, Noemi Espurz, Vishal Dhamal, Delphine Réa

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: